Amygdala reduction in patients with ADHD compared with major depression and healthy volunteers

Acta Psychiatr Scand. 2010 Feb;121(2):111-8. doi: 10.1111/j.1600-0447.2009.01489.x. Epub 2009 Oct 30.

Abstract

Objective: Results in adult attention deficit hyperactivity disorder (ADHD) on structural brain changes and the clinical relevance are contradictory. The aim of this study was to investigate whether in adult patients with ADHD hippocampal or amygdala volumes differs from that in healthy controls and patients with major depression (MD).

Method: Twenty patients with ADHD, 20 matched patients with MD and 20 healthy controls were studied with high resolution magnetic resonance imaging.

Results: Amygdala volumes in patients with ADHD were bilaterally smaller than in patients with MD and healthy controls. In ADHD, more hyperactivity and less inattention were associated with smaller right amygdala volumes, and more symptoms of depression with larger amygdala volumes.

Conclusion: This study supports findings that the amygdala plays an important role in the systemic brain pathophysiology of ADHD. Whether patients with ADHD and larger amygdala volumes are more vulnerable to affective disorders needs further investigation.

Publication types

  • Comparative Study

MeSH terms

  • Amygdala / anatomy & histology*
  • Attention Deficit Disorder with Hyperactivity / diagnosis*
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / physiopathology
  • Brain / physiopathology
  • Cross-Sectional Studies
  • Depressive Disorder, Major / diagnosis*
  • Depressive Disorder, Major / drug therapy
  • Depressive Disorder, Major / psychology
  • Diagnostic and Statistical Manual of Mental Disorders
  • Health Status*
  • Hippocampus / anatomy & histology*
  • Humans
  • Life Change Events
  • Magnetic Resonance Imaging
  • Methylphenidate
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Severity of Illness Index
  • Surveys and Questionnaires

Substances

  • Serotonin Uptake Inhibitors
  • Methylphenidate